Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72,548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity.
van Hauten PMM, Hooijmaijers L, Vidal-Manrique M, van der Waart AB, Hobo W, Wu J, Blijlevens NMA, Jansen JH, Walcheck B, Schaap NPM, de Jonge PKJD, Dolstra H. van Hauten PMM, et al. Among authors: wu j. Cytotherapy. 2024 Mar;26(3):252-260. doi: 10.1016/j.jcyt.2023.11.009. Epub 2023 Dec 19. Cytotherapy. 2024. PMID: 38127030 Free article.
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.
Matson AW, Hullsiek RH, Dixon KJ, Wang S, Lindstedt AJ, Friess RR, Phung SK, Freedman TS, Felices M, Truckenbrod EN, Wu J, Miller JS, Walcheck B. Matson AW, et al. Among authors: wu j. bioRxiv [Preprint]. 2024 May 14:2024.05.09.593347. doi: 10.1101/2024.05.09.593347. bioRxiv. 2024. PMID: 38798522 Free PMC article. Preprint.
72,548 results
You have reached the last available page of results. Please see the User Guide for more information.